It was revealed that the BRCA1 expression level increased along with the elevation of Olaparib dose in these cell lines (Fig. 3B) which was also explicable that tumor cells strengthened the ability to repair DNA damage by upregulating BRCA1 when PARP was inhibited. Here, BRCA1 is linked to neoplasm.